Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging
Recruiting
N/A
Interventional Study
Left Ventricle Function
Transcatheter Aortic Valve Replacement (TAVR)
Aortic Valve Stenosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 190 (estimated)
- Sponsor
- IRCCS Policlinico S. Donato · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to enhance and streamline intracardiac 4D Flow magnetic resonance imaging (MRI) processing by increasing automation for the quantitative and systematic assessment of left ventricular (LV) dysfunction. The study is designed to achieve the following three objectives.
The primary objective is to develop a convolutional neural network (CNN)-based deep learning model for the automatic …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients (age \> 18 years old);
* Diagnosis of severe AS defined according to ESC guidelines with indication to TAVR;
* Severe aortic stenosis both in normal/high flow status and in low flow status;
* Signed informed written consent.
Exclusion Criteria:
* Contraindicat…
Contacts